antalarmin has been researched along with cp 154526 in 5 studies
| Studies (antalarmin) | Trials (antalarmin) | Recent Studies (post-2010) (antalarmin) | Studies (cp 154526) | Trials (cp 154526) | Recent Studies (post-2010) (cp 154526) |
|---|---|---|---|---|---|
| 181 | 0 | 76 | 20 | 0 | 5 |
| 181 | 0 | 76 | 129 | 1 | 40 |
| Protein | Taxonomy | antalarmin (IC50) | cp 154526 (IC50) |
|---|---|---|---|
| Corticotropin-releasing factor receptor 1 | Homo sapiens (human) | 0.0134 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldrich, PE; Arvanitis, A; Bakthavatchalam, R; Beck, JP; Cheeseman, RS; Chidester, D; Chien, BM; Chorvat, RJ; Cocuzza, AJ; Curry, M; Fernandez, CH; Fitzgerald, LW; Gilligan, PJ; Hobbs, FW; Hodge, CN; Huang, SM; Klaczkiewicz, JD; Krenitsky, P; Rescinito, JP; Shen, HL; Wasserman, ZR; Wilde, RG; Wong, YN; Yarem, JA; Zaczek, R | 1 |
| Chen, TK; Crowe, PD; Dyck, B; Grey, J; Grigoriadis, DE; Gross, RS; Guo, Z; Haddach, M; Kiankarimi, M; Lanier, M; Li, BF; Luo, Z; McCarthy, JR; Moorjani, M; Saunders, J; Sullivan, R; Tellew, JE; Williams, JP; Zamani-Kord, S; Zhang, X | 1 |
| Gilligan, PJ; Robertson, DW; Zaczek, R | 1 |
| Grigoriadis, DE; Heinrichs, SC; McCarthy, JR | 1 |
| Houshyar, H; Hsin, LW; Jutkiewicz, EM; Rice, KC; Wood, SK; Woods, JH | 1 |
2 review(s) available for antalarmin and cp 154526
| Article | Year |
|---|---|
Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents.
Topics: Amino Acid Sequence; Animals; Humans; Molecular Sequence Data; Receptors, Corticotropin-Releasing Hormone; Stress, Physiological | 2000 |
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
Topics: Animals; Anxiety; Depression; Drug Design; Humans; Kinetics; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Seizures; Substance-Related Disorders | 1999 |
3 other study(ies) available for antalarmin and cp 154526
| Article | Year |
|---|---|
Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Dogs; Humans; Mice; Pyridines; Pyrimidines; Rats; Receptors, Corticotropin-Releasing Hormone; Recombinant Proteins; Structure-Activity Relationship | 1999 |
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Animals; Blood-Brain Barrier; CHO Cells; Corticotropin-Releasing Hormone; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Injections, Intravenous; Male; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stereoisomerism; Structure-Activity Relationship | 2005 |
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Corticotropin-Releasing Hormone; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Psychological; Swimming; Triazoles | 2005 |